title: Coffee consumption and risk of levodopa-induced dyskinesia in Parkinson's disease: The FRAGAMP study.
authors.affiliation: Dipartimento G.F. Ingrassia, Sezione di Neuroscienze, Università Degli Studi di Catania, Catania, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Nicoletti
authors.affiliation: Dipartimento G.F. Ingrassia, Sezione di Neuroscienze, Università Degli Studi di Catania, Catania, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Zappia
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D000978:Antiparkinson Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D003069:Coffee / Q000378:metabolism*; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy
chemical_list: D000978:Antiparkinson Agents; D003069:Coffee; D007980:Levodopa